Walgreens Boots Alliance (WBA)

• Market cap: $8.1B
• 1 day: -2.49%
• 5 days: -1.16%
• 1 month: 4.45%
• 3 months: 4.69%
• 6 months: -19.00%
• Year to date: -64.80%
• 1 year: -64.80%
• 5 years: -84.08%
• 10 years: -87.67%
• Sector: Consumer Discretionary
• Industry: Drug Stores & Proprietary Stores

About: Walgreens Boots Alliance is one of the largest retail pharmacy chains in the US, with over 8,000 locations. Nearly three quarters of Americans live within five miles of a Walgreens location. Roughly two thirds of revenue is generated from prescription drug sales; Walgreens makes up 20% of total prescription revenue in the US. Walgreens also generates sales from retail products (general wellness consumables and its own branded merchandise), European drug wholesale, and healthcare. With more locations incorporating additional services like Health Corner and Village Medical, Walgreens creates an omnichannel experience for patients and positions itself as a one-stop healthcare provider.

Employees: 312,000

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

0% more funds holding in top 10

Funds holding in top 10: 4 [Q2] → 4 (+0) [Q3]

2.6% less ownership

Funds ownership: 62.05% [Q2] → 59.45% (-2.6%) [Q3]

6% less funds holding

Funds holding: 916 [Q2] → 861 (-55) [Q3]

11% less call options, than puts

Call options by funds: $246M | Put options by funds: $274M

18% less repeat investments, than reductions

Existing positions increased: 276 | Existing positions reduced: 337

29% less capital invested

Capital invested by funds: $6.48B [Q2] → $4.62B (-$1.86B) [Q3]

33% less first-time investments, than exits

New positions opened: 114 | Existing positions closed: 169

Research analyst outlook

8 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $7 25% downside
• Avg. target: $9.63 3% upside
• High target: $14 49% upside

8 analyst ratings

• positive: 1 13%
• neutral: 5 63%
• negative: 2 25%

RBC Capital Ben Hendrix 27% 1-year accuracy 19 / 71 met price target	4% downside $9	Sector Perform Maintained	4 Dec 2024
Jefferies Brian Tanquilut 54% 1-year accuracy 7 / 13 met price target	4% downside $9	Hold Maintained	23 Oct 2024
TD Cowen Charles Ryhee 29% 1-year accuracy 2 / 7 met price target	49% upside $14	Buy Maintained	22 Oct 2024
UBS Kevin Caliendo 56% 1-year accuracy 9 / 16 met price target	7% upside $10	Neutral Maintained	17 Oct 2024
Barclays Steve Valiquette 75% 1-year accuracy 9 / 12 met price target	15% downside $8	Underweight Maintained	16 Oct 2024